Fig. 3From: A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trialCumulative ICU admission in the cholecalciferol and control groups. Symbols represent censoring eventsBack to article page